A notable advancement in diabetes care is emerging with the approval of tirzepatide in a 45mg form. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and delivers a https://phoebeeoip501943.hamachiwiki.com/2338551/revolutionary_introduction_tirzepatide_dose_for_blood_sugar_control